Pharmacy Practice News
Entresto, a combination of sacubitril and valsartan, has been FDA approved to directly treat patients with heart failure (HF) with preserved ejection fraction (HFpEF)
Fierce Biotech
Results from two phase 3 SURPASS trials found that Tirzepatide significantly reduced A1C and body weight in people with type 2 diabete
Practice Update
American Heart Association Releases Scientific Statement on Menopause Transition and CVD Risk
Medscape
FDA approved evinacumab-dgnb for patients with Homozygous familial hypercholesterolemia (HoFH)
Journal of the American College of Cardiology
ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization
Study examines SGLT2i and GLP-1RA in Older Adults With T2D
CMHC is proud to announce Dr. Keith C. Ferdinand—Professor of Medicine at Tulane University and Tulane Heart and Vascular Institute in New Orleans and member of the CMHC Senior Planning Committee— as the CMHC Spring 2021 Keynote Address speaker.
Faculty Spotlight
Explore valuable clinical topics with CMHC faculty member through our faculty spotlight page
Cardiometabolic Health Congress, 1801 North Military, Suite 200, Boca Raton, Florida 33431, United States, 877.571.4700
Unsubscribe Manage preferences